Home Your basket
• Tuberculosis of the laryn...
   Price 5.50 €
• Sphenoid arachnoidocele: ...
   Price 8.50 €
• Recent advances in surger...
   Price 5.50 €
• Paediatric airway endosco...
   Price 5.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Idiopathic sudden deafnes...
   Price 10.50 €
• Genotype – phenotype corr...
   Price 8.50 €
• Voice rehabilitation afte...
   Price 10.50 €
• Oncocytoma of the parotid...
   Price 8.50 €
• Saddle nose surgery: Long...
   Price 10.50 €
• A rare case of sarcoidosi...
   Price 5.50 €
• Evaluation of the use of ...
   Price 8.50 €
• Middle ear barotraumas du...
   Price 8.50 €
• Dehiscence of the anterio...
   Price 8.50 €
• Major orbital complicatio...
   Price 8.50 €
• Results of fine needle as...
   Price 10.50 €
• Argon Plasma Coagulation ...
   Price 5.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Fistulisation of a tuberc...
   Price 5.50 €
• Enlarged marginal incisio...
   Price 10.50 €
• The pedicled musculo-cuta...
   Price 8.50 €
• Notes on voice and speech...
   Price 8.50 €
• What we don’t know about ...
   Price 12.50 €
• Cleft palate and otitis m...
   Price 10.50 €
• Cervical surgical emphyse...
   Price 5.50 €
• Termino-terminal hypoglos...
   Price 10.50 €
• Partial hearing recovery ...
   Price 5.50 €
• The effects of pregnancy ...
   Price 14.00 €
• ...
   Price 5.50 €
• Papillary carcinoma arisi...
   Price 5.50 €
• Rehabilitation strategies...
   Price 10.50 €
• Extraction of the esophag...
   Price 8.50 €
• Value of the preservation...
   Price 14.00 €
• Human skull development a...
   Price 10.50 €
• Evaluation and treatment ...
   Price 8.50 €

Total Order 297.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2001 o

RHINOLOGY

Mucosal melanomas of the head and neck. Experience of the Salah Azaiz Institute (Tunis).


Authors : Z. Oueslati, S. Touati, S. Gritli, A. El-May, F. Benna, H. Boussen, A. El-Khedim, M. Ferjaoui, A. Ladgham (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:237-240.

Article published in french
Downloadable PDF document french



Summary : The mucosal melanoma of the head and neck is rare and of late diagnosis. This retrospective study concerns 17 cases brought together in 30 years. Sex-ratio was of 1,1, the average age of 58 years. Tumoral seats were the following ones : nasal cavity and paranasal sinus (n=10), nasopharyngeal cavity (n=2), gingival seat (n=2), palate (n=1), laryngeal seat (n=1), middle ear (n=1). Tumoral extension was classified an follows: stage I: 52,9%, stage II: 17,6%, stage III: 29,4%. Melanomas were achromic in 23,5% of cases. On the therapeutic plan, 47,1% of the patients were treated in a purpose palliative because of the importance of the tumoral extension. Seven patients (41,2%) were treated surgically ; three among them received an additional radiotherapy for an insufficient tumoral excision or adenopathy in break capsular. Two patients (11,8%) were treated by exclusive radiotherapy. The rates of survival were 17,6% in 2 years, and 5,9% in 5 years. The average duration of survival was of 18,1 months. The causes of failure were essentially local and metastatic.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE